Labtec GmbH Report issue

For profit Phase 2
Founded: Germany (1990)
Status: No NME R&D (1990)

Organization Overview

First Clinical Trial
2010
NCT00943566
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

morphine (1 trial)

sufentanil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Pain (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2